Pulike Biological Engineering, Inc.

¥9.34As of Sun 8 Nov 2026, 12:00 UTC
SSE:603566Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (7.54%)
Div yield 6.42%
ROE 3.23%
Biotechnology
Beta (5Y) 0.37
PE TTM 30.07
TSR TTM (30.61%)
Mkt cap ¥3.194B
ROIC 2.72%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥11
13.31%
(64.05%)
Sell 4|3|6|0|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.09
0.10
(4.75%)
(6.61%)
(10.75%)
1.59%
Revenue¥M
254.8
247.7
249.2
261.5
2.12%
0.13%
(4.88%)
0.47%
Peers (US$478.7M)
Cap (US$)
PE
475.3M
—
462.3M
43.75x
Capital
TTM
5Y
10Y
Leveragex
2.447
(0.037)
(0.033)
EBIT/Intx
4.050
0.938
0.892
Own earn%
77.07
21.82
2.12
Sh yield%
32.96
29.04
35.91
Owners
Insiders/Inst%
12.90
40.92
Short interest%
4.44
SBC / revenue%
2.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
11–14
$1 testx
—
Incr. ROIC%
6